Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon

被引:25
作者
Sharara, AI
Chedid, M
Araj, GF
Barada, KA
Mourad, FH
机构
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon
[2] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon
关键词
Helicobacter pylori; antimicrobial resistance; antibiotics;
D O I
10.1016/S0924-8579(01)00482-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to determine the prevalence of antimicrobial resistance amongst Helicobacter pylori isolates cultured from gastric biopsies taken during routine endoscopies at the American University of Beirut Medical Center in Lebanon. Fifty-four consecutively recovered H. pylori isolates were tested against metronidazole, clarithromycin, tetracycline and amoxycillin using the epsilometer test. Resistance to metronidazole (MIC > 8 mg/l) was found in 29.5% of the isolates while resistance to clarithromycin (MIC greater than or equal to0.25 mg/l) and tetracycline (MIC greater than or equal to 4 mg/l) was low (4 and 2%, respectively). All isolates were susceptible to amoxycillin (MIC less than or equal to 8 mg/l). These findings are comparable with those reported from Europe and the United States. The prevalence of metronidazole resistance in our study was lower than that from other parts of the Middle East and the developing world. (C) 2002 Elsevier Science B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 24 条
[1]  
ADEYEMI E, 1992, ITAL J GASTROENTEROL, V24, P436
[2]   Evolution of metronidazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia [J].
Al-Qurashi, AR ;
El-Morsy, F ;
Al-Quorain, AA .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (03) :233-236
[3]   Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria [J].
Ani, AE ;
Malu, AO ;
Onah, JA ;
Queiroz, DMM ;
Kirschner, G ;
Rocha, GA .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1999, 93 (06) :659-661
[4]  
Bartolome OL, 1998, REV CLIN ESP, V198, P420
[5]  
Bindayna KM, 2001, SAUDI MED J, V22, P53
[6]   Clinical economics review: Helicobacter pylori-associated peptic ulcer disease [J].
Bodger, K ;
Daly, MJ ;
Heatley, RV .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) :273-282
[7]   Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria [J].
Boyanova, L ;
Stancheva, I ;
Spassova, Z ;
Katzarov, N ;
Mitov, I ;
Koumanova, R .
JOURNAL OF MEDICAL MICROBIOLOGY, 2000, 49 (05) :415-418
[8]  
Fock KM, 2000, ALIMENT PHARM THER, V14, P225, DOI 10.1046/j.1365-2036.2000.00691.x
[9]   DUODENAL-ULCER TREATED WITH HELICOBACTER-PYLORI ERADICATION - 7-YEAR FOLLOW-UP [J].
FORBES, GM ;
GLASER, ME ;
CULLEN, DJE ;
WARREN, JR ;
CHRISTIANSEN, KJ ;
MARSHALL, BJ ;
COLLINS, BJ .
LANCET, 1994, 343 (8892) :258-260
[10]   RANDOMIZED CONTROLLED TRIAL OF SHORT-TERM TREATMENT TO ERADICATE HELICOBACTER-PYLORI IN PATIENTS WITH DUODENAL-ULCER [J].
HOSKING, SW ;
LING, TKW ;
YUNG, MY ;
CHENG, A ;
CHUNG, SCS ;
LEUNG, JWC ;
LI, AKC .
BRITISH MEDICAL JOURNAL, 1992, 305 (6852) :502-504